Extramedullary progression of multiple myeloma despite concomitant medullary response to multiple combination therapies and autologous transplant: a case report

INTRODUCTION: Extramedullary myeloma that occurs during the clinical course of multiple myeloma is rare but is an independent poor prognostic factor with mortality of 73% and median survival of 12 months despite aggressive therapies including novel agents. The clinicopathological aspects, biology an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasi Loknath Kumar, Anup, Dakhil, Christopher, Teeka Satyan, Megha, Haideri, Nisreen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168996/
https://www.ncbi.nlm.nih.gov/pubmed/25200389
http://dx.doi.org/10.1186/1752-1947-8-299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168996/
https://www.ncbi.nlm.nih.gov/pubmed/25200389
http://dx.doi.org/10.1186/1752-1947-8-299

Ejemplares similares